Biocon Limited (NSE: BIOCON)
India
· Delayed Price · Currency is INR
335.95
-14.40 (-4.11%)
Dec 20, 2024, 3:29 PM IST
Biocon Revenue
Biocon had revenue of 35.90B INR in the quarter ending September 30, 2024, with 3.70% growth. This brings the company's revenue in the last twelve months to 148.94B, up 9.52% year-over-year. In the fiscal year ending March 31, 2024, Biocon had annual revenue of 147.56B with 32.05% growth.
Revenue (ttm)
148.94B
Revenue Growth
+9.52%
P/S Ratio
2.70
Revenue / Employee
9.13M
Employees
16,315
Market Cap
402.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 147.56B | 35.82B | 32.05% |
Mar 31, 2023 | 111.74B | 29.90B | 36.54% |
Mar 31, 2022 | 81.84B | 10.41B | 14.57% |
Mar 31, 2021 | 71.43B | 8.43B | 13.37% |
Mar 31, 2020 | 63.01B | 7.86B | 14.26% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBiocon News
- 6 days ago - Stocks to watch, December 16: Biocon, Lupin, Bharat Forge, Radico Khaitan, Dixon Tech, and Aurobindo Pharma and more in focus today - Business Upturn
- 10 days ago - Pharma stocks: Divi’s Lab (+0.82%), IPCA (+0.83%) rise; Biocon (-1.86%), Glaxo (-1.44%) decline - Business Upturn
- 18 days ago - Pharma Stocks: Cipla down nearly 2%, Ajanta Pharma down 1.45%, Abbott India up 1.27% - Business Upturn
- 20 days ago - Biocon shares surge nearly 3% after FDA nod for Yesintek, a biosimilar to Stelara - Business Upturn
- 20 days ago - Stocks to watch today: Maruti Suzuki, TVS Motor, Biocon, DLF, RVNL, RBL, Cipla, Home First, Cochin Shipyard in focus - Business Upturn
- 21 days ago - Pharma stocks weekly roundup: Biocon leads with 9.08% gain, Torrent Pharma up 4.91%, Lupin dips 1.82% - Business Upturn
- 5 weeks ago - Biocon shares surge over 3% after Bengaluru facilities get VAI Tag from USFDA - Business Upturn
- 5 weeks ago - Stocks to watch today: Divi’s Laboratories, JSW Steel, LIC, Biocon in focus; Asian Paints, Tata Motors, Aurobindo Pharma, Ola Electric under pressure - Business Upturn